A. Natarajan

Costs and cost‐effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: Results from the SAPPHIRE trial

W. Gray, T. Lavelle, E. Mahoney, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

MS disease activity in RESTORE

X. Montalban, L. Kappos, H. Hartung, 2014, Neurology.

Longitudinal Stability of Anti-JC Virus Antibody Status in Multiple Sclerosis Patients: Results of STRATIFY-1 (S30.001)

M. Subramanyam, T. Plavina, G. Bloomgren, 2013 .

Anti-JCV Antibody Prevalence in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Natalizumab: Baseline Results of STRATIFY-2 (S41.002)

A. Sandrock, M. Subramanyam, T. Plavina, 2012 .

Anti‐John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY‐1

A. Sandrock, M. Subramanyam, T. Plavina, 2011, Annals of neurology.

Haematopoietic and immunologic abnormalities in severe aplastic anaemia patients treated with anti‐thymocyte globulin

H. Kluin-Nelemans, G. Beverstock, A. Brand, 1989, British journal of haematology.

Risk of natalizumab-associated progressive multifocal leukoencephalopathy.

Meena Subramanyam, A. Sandrock, C. Hotermans, 2012, The New England journal of medicine.

Pharmacokinetics of Oral Tonapofylline and Its Acyl‐Glucuronide Metabolite in Patients With Mild and Moderate Hepatic Impairment

K. Lasseter, T. Marbury, A. Deykin, 2012, Journal of clinical pharmacology.

PERIPHERAL VASCULAR DISEASE Original Studies Costs and Cost-Effectiveness of Carotid Stenting versus Endarterectomy for Patients at Increased Surgical Risk: Results From the SAPPHIRE Trial

E. Mahoney, M. Wholey, R. Berezin, 2011 .